Ad
AIMT - Aimmune Therapeutics Stock Trading
About | Aimmune Therapeutics Inc. (NASDAQ:AIMT)
Not available
Quote | Aimmune Therapeutics Inc. (NASDAQ:AIMT)
| Last: | $34.49 |
|---|---|
| Change Percent: | -0.29% |
| Open: | $34.56 |
| Close: | $34.49 |
| High: | $34.56 |
| Low: | $34.48 |
| Volume: | 969,191 |
| Last Trade Date Time: | 10/12/2020 04:44:59 am |
News | Aimmune Therapeutics Inc. (NASDAQ:AIMT)
-
— Majority of Patients Experienced Low Rates of Adverse Events, Which Declined in Frequency and Severity with Continued Treatment — — Systemic Allergic Reactions and Epinephrine Use Were Low and Decreased Over Time — Aimmune Therapeutics, ...
-
-- Peanut Allergy is One of the Most Common Food Allergies in Europe -- -- Up to 1.6% of European Children Live with Potentially Life-Threatening Peanut Allergy -- Aimmune Therapeutics, Inc., a Nestlé Health Science Company, today announced that the European Com...
Message Board Posts | Aimmune Therapeutics Inc. (NASDAQ:AIMT)
| Subject | By | Source | When |
|---|---|---|---|
| znewcar1: AIMT 171% v44,6M c34.22 f65,4M | znewcar1 | investorshangout | 08/31/2020 8:24:24 PM |
| whytestocks: $AIMT News Article - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Ai | whytestocks | investorshangout | 08/31/2020 4:15:47 PM |
| whytestocks: $AIMT News Article - (AIMT) Alert: Johnson Fistel Investigates Proposed Sale of Aimmune | whytestocks | investorshangout | 08/31/2020 2:05:46 PM |
| whytestocks: $AIMT News Article - Aimmune Therapeutics Enters Definitive Agreement with Soci t s des | whytestocks | investorshangout | 08/31/2020 2:00:47 PM |
| Wrong! As of March 13th the short interest | dmiller | investorshub | 04/04/2020 12:54:02 PM |
News, Short Squeeze, Breakout and More Instantly...
Aimmune Therapeutics Inc. Company Name:
AIMT Stock Symbol:
NASDAQ Market:
Ad
-
— Majority of Patients Experienced Low Rates of Adverse Events, Which Declined in Frequency and Severity with Continued Treatment — — Systemic Allergic Reactions and Epinephrine Use Were Low and Decreased Over Time — Aimmune Therapeutics, ...
-
-- Peanut Allergy is One of the Most Common Food Allergies in Europe -- -- Up to 1.6% of European Children Live with Potentially Life-Threatening Peanut Allergy -- Aimmune Therapeutics, Inc., a Nestlé Health Science Company, today announced that the European Com...
-
VEVEY, Switzerland , Sept. 14, 2020 /PRNewswire/ -- Société des Produits Nestlé S.A. ("Nestlé") announced that its wholly-owned subsidiary, SPN Merger Sub, Inc. ("Purchaser"), is commencing today a cash tender offer to purchase all of the outstanding shares of common s...